Reply to E.A. Rakha et al

Antonio C Wolff¹, M Elizabeth H Hammond², David G Hicks³, Kimberly H Allison⁴, John M S Bartlett⁵, Michael Bilous⁶, Patrick Fitzgibbons⁷, Wedad Hanna⁸, Robert B Jenkins⁹, Pamela B Mangu¹⁰, Soonmyung Paik¹¹, Edith A Perez¹², Michael F Press¹³, Patricia A Spears¹⁴, Gail H Vance¹⁵, Giuseppe Viale¹⁶, Mitch Dowsett¹⁷, Lisa M McShane¹⁸, Daniel F Hayes¹⁹

Affiliations

¹ Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.
² University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT.
³ University of Rochester Medical Center, Rochester, NY.
⁴ Stanford University Medical Center, Stanford, CA.
⁵ Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
⁶ University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia.
⁷ St Jude Medical Center, Fullerton, CA.
⁸ Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
⁹ Mayo Clinic, Rochester, MN.
¹⁰ American Society of Clinical Oncology, Alexandria, VA.
¹¹ National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA.
¹² Mayo Clinic, Jacksonville, FL.
¹³ University of Southern California, Los Angeles, CA.
¹⁴ North Carolina State University, Raleigh, NC.
¹⁵ Indiana University Medical Center, Indianapolis, IN.
¹⁶ University of Milan, European Institute of Oncology, Milan, Italy.
¹⁷ Royal Marsden Hospital, London, United Kingdom.
¹⁸ National Cancer Institute, Bethesda, MD.
¹⁹ University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.

PMID: 25753441
DOI: 10.1200/JCO.2014.59.7559

Comment

Reply to E.A. Rakha et al

Antonio C Wolff et al. J Clin Oncol. 2015.

. 2015 Apr 10;33(11):1302-4.

doi: 10.1200/JCO.2014.59.7559. Epub 2015 Mar 9.

Authors

Affiliations

¹ Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.
² University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT.
³ University of Rochester Medical Center, Rochester, NY.
⁴ Stanford University Medical Center, Stanford, CA.
⁵ Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
⁶ University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia.
⁷ St Jude Medical Center, Fullerton, CA.
⁸ Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
⁹ Mayo Clinic, Rochester, MN.
¹⁰ American Society of Clinical Oncology, Alexandria, VA.
¹¹ National Adjuvant Surgical Breast and Bowel Project, Pittsburgh, PA.
¹² Mayo Clinic, Jacksonville, FL.
¹³ University of Southern California, Los Angeles, CA.
¹⁴ North Carolina State University, Raleigh, NC.
¹⁵ Indiana University Medical Center, Indianapolis, IN.
¹⁶ University of Milan, European Institute of Oncology, Milan, Italy.
¹⁷ Royal Marsden Hospital, London, United Kingdom.
¹⁸ National Cancer Institute, Bethesda, MD.
¹⁹ University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.

PMID: 25753441
DOI: 10.1200/JCO.2014.59.7559

No abstract available

PubMed Disclaimer

Comment on

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. Wolff AC, et al. J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101045
National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancer.
Rakha EA, Pigera M, Shaaban A, Shin SJ, D'Alfonso T, Ellis IO, Lee AH. Rakha EA, et al. J Clin Oncol. 2015 Apr 10;33(11):1301-2. doi: 10.1200/JCO.2014.59.7211. Epub 2015 Mar 9. J Clin Oncol. 2015. PMID: 25753440 No abstract available.

Cited by

New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.
Tchrakian N, Flanagan L, Harford J, Gannon JM, Quinn CM. Tchrakian N, et al. Virchows Arch. 2016 Feb;468(2):207-11. doi: 10.1007/s00428-015-1871-z. Epub 2015 Oct 31. Virchows Arch. 2016. PMID: 26521061
EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.
Mahmud Z, Gomes AR, Lee HJ, Aimjongjun S, Jiramongkol Y, Yao S, Zona S, Alasiri G, Gong G, Yagüe E, Lam EW. Mahmud Z, et al. Cancers (Basel). 2019 Jul 28;11(8):1067. doi: 10.3390/cancers11081067. Cancers (Basel). 2019. PMID: 31357743 Free PMC article.
[Update of the German S3 breast cancer guideline : What is new for pathologists?].
Lebeau A, Denkert C, Sinn P, Schmidt M, Wöckel A. Lebeau A, et al. Pathologe. 2019 Mar;40(2):185-198. doi: 10.1007/s00292-019-0578-3. Pathologe. 2019. PMID: 30847505 German.
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation.
Ahn S, Woo JW, Lee K, Park SY. Ahn S, et al. J Pathol Transl Med. 2020 Jan;54(1):34-44. doi: 10.4132/jptm.2019.11.03. Epub 2019 Nov 6. J Pathol Transl Med. 2020. PMID: 31693827 Free PMC article. Review.
Long term side effects of adjuvant chemotherapy in patients with early breast cancer.
Tao JJ, Visvanathan K, Wolff AC. Tao JJ, et al. Breast. 2015 Nov;24 Suppl 2(0 2):S149-53. doi: 10.1016/j.breast.2015.07.035. Epub 2015 Aug 20. Breast. 2015. PMID: 26299406 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

P30 CA006973/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to E.A. Rakha et al

Affiliations

Reply to E.A. Rakha et al

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical